Status:
COMPLETED
A Crossover Trial to Examine the Efficacy of a Powder to Improve Sleep Quality and Performance
Lead Sponsor:
Beam
Collaborating Sponsors:
Citruslabs
Conditions:
Sleep
Sleep Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a randomized, placebo-controlled crossover study to assess the efficacy of BEAM's Dream Powder in improving sleep health among 40 adults. Participants will use a placebo for 2 weeks, followed ...
Eligibility Criteria
Inclusion
- Male or female
- 18+ years old
- Self-reported issues with sleeping, falling asleep, or staying asleep.
- Willing to discontinue any supplements, medications, herbal remedies, or melatonin products used to assist with sleep for the study duration.
- Willing to avoid introducing any other supplements, medications, herbal remedies, or melatonin products used to assist with sleep for the duration of this trial.
- Willing to maintain their standard sleep pattern and activity level for the duration of the study.
- Be generally healthy and not live with any uncontrolled chronic disease.
Exclusion
- Diagnosed with any chronic sleep condition, including but not limited to insomnia, narcolepsy, or sleep apnea.
- Women who are pregnant, breastfeeding, or trying to conceive.
- Anyone unwilling or unable to follow the study protocol.
- Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
- Is currently undergoing, or planning to undergo, any significant medical procedures during the study period.
- Has undergone any surgeries or invasive treatments in the last six months.
- A history of severe allergic reactions, including but not limited to any of the product's ingredients.
- Anyone with a nut allergy.
- Heavy drinkers. A heavy drinker is considered to be a woman who drinks 8 or more alcoholic drinks per week or a man who drinks 15 or more alcoholic drinks per week.
- Anyone who uses illicit drugs.
- Use any prescription medication, over-the-counter, or herbal remedies that can affect sleep.
- Have a job that involves working the third or night shifts.
Key Trial Info
Start Date :
July 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 17 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07183735
Start Date
July 2 2024
End Date
October 17 2024
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Citruslabs
Las Vegas, Nevada, United States, 89118